Literature DB >> 19875446

Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonylglycine inhibition of glycine transport.

Amelia R Edington1, Audra A McKinzie1, Aaron J Reynolds2, Michael Kassiou3, Renae M Ryan1, Robert J Vandenberg4.   

Abstract

Concentrations of extracellular glycine in the central nervous system are regulated by Na(+)/Cl(-)-dependent glycine transporters, GLYT1 and GLYT2. N-Arachidonylglycine (NAGly) is an endogenous inhibitor of GLYT2 with little or no effect on GLYT1 and is analgesic in rat models of neuropathic and inflammatory pain. Understanding the molecular basis of NAGly interactions with GLYT2 may allow for the development of novel therapeutics. In this study, chimeric transporters were used to determine the structural basis for differences in NAGly sensitivity between GLYT1 and GLYT2 and also the actions of a series of related N-arachidonyl amino acids. Extracellular loops 2 and 4 of GLYT2 are important in the selective inhibition of GLYT2 by NAGly and by the related compounds N-arachidonyl-gamma-aminobutyric acid and N-arachidonyl-d-alanine, whereas only the extracellular loop 4 of GLYT2 is required for N-arachidonyl-l-alanine inhibition of transport. These observations suggest that the structure of the head group of these compounds is important in determining how they interact with extracellular loops 2 and 4 of GLYT2. Site-directed mutagenesis of GLYT2 EL4 residues was used to identify the key residues Arg(531), Lys(532), and Ile(545) that contribute to the differences in NAGly sensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875446      PMCID: PMC2794758          DOI: 10.1074/jbc.M109.017509

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously.

Authors:  Nikolai A Shevchuk; Anton V Bryksin; Yevgeniya A Nusinovich; Felipe C Cabello; Margaret Sutherland; Stephan Ladisch
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

2.  The distribution of glycine in cat spinal cord and roots.

Authors:  M H Aprison; R Werman
Journal:  Life Sci       Date:  1965-11       Impact factor: 5.037

3.  A competitive inhibitor traps LeuT in an open-to-out conformation.

Authors:  Satinder K Singh; Chayne L Piscitelli; Atsuko Yamashita; Eric Gouaux
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

Review 4.  Molecular structure and function of the glycine receptor chloride channel.

Authors:  Joseph W Lynch
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

5.  Cloning, expression, and localization of a rat brain high-affinity glycine transporter.

Authors:  J Guastella; N Brecha; C Weigmann; H A Lester; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features.

Authors:  Q R Liu; B López-Corcuera; S Mandiyan; H Nelson; N Nelson
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

7.  Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.

Authors:  Katsuya Morita; Naoyo Motoyama; Tomoya Kitayama; Norimitsu Morioka; Koki Kifune; Toshihiro Dohi
Journal:  J Pharmacol Exp Ther       Date:  2008-04-30       Impact factor: 4.030

8.  Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.

Authors:  Jesús Gomeza; Koji Ohno; Swen Hülsmann; Wencke Armsen; Volker Eulenburg; Diethelm W Richter; Bodo Laube; Heinrich Betz
Journal:  Neuron       Date:  2003-11-13       Impact factor: 17.173

9.  Zn2+ inhibits glycine transport by glycine transporter subtype 1b.

Authors:  Pengchu Ju; Karin R Aubrey; Robert J Vandenberg
Journal:  J Biol Chem       Date:  2004-03-18       Impact factor: 5.157

10.  Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.

Authors:  J L Arriza; W A Fairman; J I Wadiche; G H Murdoch; M P Kavanaugh; S G Amara
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

View more
  12 in total

Review 1.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT.

Authors:  Andrew J Gilmore; Marika Heblinski; Aaron Reynolds; Michael Kassiou; Mark Connor
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Transmission pathways and mediators as the basis for clinical pharmacology of pain.

Authors:  Daniel R Kirkpatrick; Dan M McEntire; Tyler A Smith; Nicholas P Dueck; Mitchell J Kerfeld; Zakary J Hambsch; Taylor J Nelson; Mark D Reisbig; Devendra K Agrawal
Journal:  Expert Rev Clin Pharmacol       Date:  2016-07-04       Impact factor: 5.045

5.  Oleoyl-L-carnitine inhibits glycine transport by GlyT2.

Authors:  J E Carland; R E Mansfield; R M Ryan; R J Vandenberg
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Biophysical Approaches to the Study of LeuT, a Prokaryotic Homolog of Neurotransmitter Sodium Symporters.

Authors:  Satinder K Singh; Aritra Pal
Journal:  Methods Enzymol       Date:  2015-03-24       Impact factor: 1.600

7.  Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.

Authors:  A Mingorance-Le Meur; P Ghisdal; B Mullier; P De Ron; P Downey; C Van Der Perren; V Declercq; S Cornelis; M Famelart; J Van Asperen; E Jnoff; J P Courade
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 8.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies.

Authors:  Francisco Zafra; Ignacio Ibáñez; Cecilio Giménez
Journal:  Neuronal Signal       Date:  2016-12-22

10.  Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.

Authors:  Jacob Andersen; Kristoffer B Ringsted; Benny Bang-Andersen; Kristian Strømgaard; Anders S Kristensen
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.